NCT03515603 is a NA clinical trial of Endoscopic resection in Pituitary Adenoma, sponsored by University of Ulm.

Who is sponsoring NCT03515603?

NCT03515603 is sponsored by University of Ulm.

What drugs are being tested in NCT03515603?

Interventions in NCT03515603: Endoscopic resection, Microsurgical resection.

What condition does NCT03515603 study?

NCT03515603 studies Pituitary Adenoma.

Is NCT03515603 still recruiting?

NCT03515603 is currently terminated. Last updated 17 May 2023.

Last reviewed 2023-05-17 · How we verify

NCT03515603

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Endocrine Outcome of Surgery for Pituitary Adenoma

Terminated NA Last updated 17 May 2023

What this trial tests

NA trial testing Endoscopic resection in Pituitary Adenoma in 36 participants. Terminated before completion.

Timeline

10 May 2018

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	University of Ulm
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	36
Start date	10 May 2018
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across Germany

Drugs / interventions tested

Endoscopic resection
Microsurgical resection

Conditions studied

Pituitary Adenoma — all drugs for Pituitary Adenoma →

Sponsor

University of Ulm

Who can join

18 and older, any sex, with Pituitary Adenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective and randomized compare between microsurgical and endoscopic transsphenoidal MRI assisted resection of pituitary adenomas.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Endocrine Outcome and Quality of Life After Transsphenoidal Resection of Pituitary Adenoma-A Prospective Randomized Single-Blinded Study Comparing Endoscopic Versus Microscopic Resection.
Pala A, Grübel N, Mayer B, Becker R, et al · · 2025 · cited 4× · PMID 39852769 · DOI 10.3390/neurolint17010005

Verify or expand the search:

Other trials of Endoscopic resection

Trials testing the same drug.

NCT07317609 — Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurg · Phase 1 · recruiting
NCT05825664 — Underwater Versus Conventional Endoscopic Mucosal Resection in the Treatment of Non-pedunculated Colorectal Polyps · NA · unknown
NCT04751591 — Study On Safety Of Endoscopic Resection For 2-5cm Gastric Gastrointestinal Stromal Tumor · NA · unknown
NCT05452265 — Minimal Invasive Surgery for Gastric Subepithelial Tumor · completed

Other recruiting trials for Pituitary Adenoma

Currently open trials in the same condition.

NCT04569591 — DDAVP for Pituitary Adenoma · NA · recruiting
NCT06831461 — Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors · NA · recruiting
NCT06973824 — A Twenty-years' Experience in Pituitary Disease. · recruiting
NCT06679816 — Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors · Phase 4 · recruiting
NCT06584123 — Molecular Pituitary Imaging Using 18F-FET PET · NA · recruiting

Other University of Ulm trials

Trials by the same sponsor.

NCT07436195 — Imprinting in Metabolic Diseases - Identifying Epigenetic Mechanisms in Human Gestational Diabetes Through Cell-free DNA · recruiting
NCT07154524 — Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) · recruiting
NCT06877143 — Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis · NA · recruiting
NCT06280079 — Ultra-high-caloric, Fatty Diet in ALS · NA · recruiting
NCT06627348 — Hilotherapy for Prevention of Chemotherapy-induced Peripheral Polyneuropathy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03515603 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Ulm
Last refreshed: 17 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03515603.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing